Matthew Duffy | Chief Business Officer |
Steve Willard | CEO & Director |
Jonathan Javitt | Chief Scientist & Director |
Seth Voorhees | CFO |
Ed Woo | Ascendiant Capital Markets |
Good day and welcome to the NRX Pharmaceuticals Incorporated Second Quarter 2023 Earnings Conference Call. [Operator Instructions].
I would now like to turn the conference over to Mr. Matthew Duffy, the company's Chief Business Officer. Please go ahead, sir.